Vildagliptin Export Market Intelligence: India's 178 Suppliers Shipping to 87 Countries — TransData Nexus 2026

Q: Who are the top vildagliptin exporters from India?

The top vildagliptin exporters from India are: 1. AJANTA PHARMA LIMITED — $1.8M (18.0% market share); 2. CADILA PHARMACEUTICALS LIMITED — $1.0M (10.1% market share); 3. INTAS PHARMACEUTICALS LIMITED — $996.7K (9.8% market share); 4. EMCURE PHARMACEUTICALS LIMITED — $984.8K (9.7% market share); 5. INNOVA CAPTAB LIMITED — $720.7K (7.1% market share). Together they account for 54.7% of India's total vildagliptin export value.

Q: What is the total export value of vildagliptin from India?

The total export value of vildagliptin from India is $10.2M USD, recorded across 1,149 shipment transactions from 178 active exporters to 87 destination countries. The average shipment value is $8.8K.

Q: Which countries import vildagliptin from India?

India exports vildagliptin to 87 countries worldwide. The top importing countries are: FRANCE (14.4% share, $1.5M), PORTUGAL (10.1% share, $1.0M), CHILE (9.1% share, $923.6K), NETHERLANDS (8.4% share, $850.5K), YEMEN (7.9% share, $807.5K). These five markets account for 49.9% of total export value.

Q: What is the HS code for vildagliptin exports from India?

The primary HS code for vildagliptin exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of vildagliptin exports from India?

The average unit price for vildagliptin exports from India is $5.68 USD per unit, with prices ranging from $0.00 to $500.00 depending on formulation, packaging, and order volume. The total market is valued at $10.2M across 1,149 shipments.

Q: Which ports handle vildagliptin exports from India?

The primary ports for vildagliptin exports from India are SAHAR AIR (14.4% of shipments), SAHAR AIR CARGO ACC (INBOM4) (11.1% of shipments), DELHI AIR (6.2% of shipments), NHAVA SHEVA SEA (INNSA1) (5.1% of shipments), DELHI AIR CARGO ACC (INDEL4) (5.1% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of vildagliptin?

India is one of the world's leading exporters of vildagliptin due to its large base of 178 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports vildagliptin to 87 countries, demonstrating 45% global market coverage.

Q: What certifications do Indian vildagliptin exporters need?

Indian vildagliptin exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import vildagliptin from India?

There are 304 registered buyers importing vildagliptin from India, spread across 87 countries. The repeat buyer rate is 62.2%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top vildagliptin supplier from India?

AJANTA PHARMA LIMITED is the leading vildagliptin exporter from India with a market share of 18.0% and total export value of $1.8M across 92 shipments. The top 5 suppliers together control 54.7% of total export value.

Suresh Sormare

Vildagliptin

India Pharmaceutical Trade Intelligence

$10.2M178 Suppliers87 CountriesHS 30049099

ExportsIndia → FRANCE14.4%India → PORTUGAL10.1%

ImportsTURKEY → India$2110.6B SPAIN → India$164.0B

#1 Supplier: AJANTA PHARMA #1 Buyer: PLANET PHARMA

Vildagliptin Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Vildagliptin to the World

Between 2022 and 2026, India exported $10.2M worth of vildagliptin across 1,149 verified shipments to 87 countries — covering 45% of world markets in the Advanced Diabetes Medications segment. The largest destination is FRANCE (14.4%). AJANTA PHARMA LIMITED leads with a 18.0% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Vildagliptin export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Vildagliptin export data snapshot — $10.2M · 178 exporters · 87 countriesTransData Nexus · Indian Customs Data

Top Vildagliptin Exporters from India

178 active exporters · Ranked by export value

View all 178 →

Top Vildagliptin Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	AJANTA PHARMA LIMITED	$1.8M	92	9	18.0%
2	CADILA PHARMACEUTICALS LIMITED

Top Countries Importing Vildagliptin from India

87 destination markets · Ranked by import value

All 87 countries →

Top Countries Importing Vildagliptin from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	FRANCE	$1.5M	14.4%
2	PORTUGAL	$1.0M	10.1%
3	CHILE	$923.6K	9.1%
4	NETHERLANDS	$850.5K	8.4%
5	YEMEN	$807.5K	7.9%
6	UNITED ARAB EMIRATES	$483.9K	4.8%
7	JORDAN	$419.7K	4.1%
8	MAURITIUS	$409.6K	4.0%
9	IRAQ	$360.1K	3.5%
10	MALDIVES	$322.2K	3.2%

FRANCE is India's largest vildagliptin export destination, absorbing 14.4% of total exports worth $1.5M. The top 5 importing countries — FRANCE, PORTUGAL, CHILE, NETHERLANDS, YEMEN — together account for 49.9% of India's total vildagliptin export value. The remaining 82 destination countries collectively receive the other 50.1%, indicating a broadly diversified export footprint across multiple regions.

Who Supplies Vildagliptin to India?

21 origin countries · Total import value: $2274.6B

India imports vildagliptin from 21 countries with a combined import value of $2274.6B. The largest supplier is TURKEY ($2110.6B, 235 shipments), followed by SPAIN and SINGAPORE. All values are from Indian Customs (DGFT) import records.

Countries Supplying Vildagliptin to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	TURKEY	$2110.6B	235	92.8%
2	SPAIN	$164.0B	24	7.2%
3	SINGAPORE	$9.5M	205	0.0%
4	SWITZERLAND	$889.1K	15	0.0%
5	BULGARIA	$103.9K	9	0.0%
6	GERMANY	$15.1K	18	0.0%
7	UNITED KINGDOM	$10.1K	9	0.0%
8	UNITED STATES	$7.8K	4	0.0%
9	BRAZIL	$5.3K	8	0.0%
10	IRELAND	$2.2K	2	0.0%

Showing top 10 of 21 origin countries

TURKEY is the largest supplier of vildagliptin to India, accounting for 92.8% of total import value. The top 5 origin countries — TURKEY, SPAIN, SINGAPORE, SWITZERLAND, BULGARIA — together supply 100.0% of India's vildagliptin imports. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Vildagliptin

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

As of March 2026, vildagliptin has not received approval from the U.S. Food and Drug Administration (FDA) for marketing in the United States. Consequently, there are no approved Abbreviated New Drug Applications (ANDAs) for vildagliptin listed in the FDA's Orange Book. This absence of approval indicates that vildagliptin cannot be legally marketed or imported into the U.S. Given that 178 Indian exporters are active in the vildagliptin market, the lack of FDA approval presents a significant barrier to accessing the U.S. pharmaceutical market.

2EU & UK Regulatory Framework

In the European Union, vildagliptin has been authorized for use in the treatment of type 2 diabetes mellitus. The European Medicines Agency (EMA) granted marketing authorization for Galvus (vildagliptin) on 26 September 2007. Additionally, combination products such as Eucreas (vildagliptin/metformin) received authorization on 14 November 2007. These approvals necessitate compliance with EU Good Manufacturing Practice (GMP) standards, ensuring that manufacturing processes meet stringent quality requirements. The UK's Medicines and Healthcare products Regulatory Agency (MHRA) continues to recognize these authorizations post-Brexit, maintaining alignment with EMA's regulatory decisions.

3WHO Essential Medicines & Global Standards

As of March 2026, vildagliptin is not listed on the World Health Organization's (WHO) Model List of Essential Medicines. Consequently, it has not undergone the WHO Prequalification Programme, which assesses the quality, safety, and efficacy of medicinal products. Regarding pharmacopoeial standards, vildagliptin is included in the European Pharmacopoeia (EP), British Pharmacopoeia (BP), and Indian Pharmacopoeia (IP), providing standardized quality benchmarks for its production and quality control.

4India Regulatory Classification

In India, vildagliptin is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) has not set a ceiling price for vildagliptin, allowing market-driven pricing. For export purposes, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC) for pharmaceutical products, ensuring compliance with export regulations and quality standards.

5Patent & Exclusivity Status

The primary patent for vildagliptin, held by Novartis, expired in 2019, opening the market to generic competition. This expiration has led to increased production and export activities by Indian pharmaceutical companies, contributing to the $10.2 million USD export value recorded between 2022 and 2026.

6Recent Industry Developments

In September 2025, the FDA established a "green list" import alert to prevent potentially dangerous GLP-1 (glucagon-like peptide-1) active pharmaceutical ingredients from unverified foreign sources from entering the U.S. market. This measure aims to safeguard consumers from illegal GLP-1 active ingredients imported from overseas.

In January 2026, the FDA requested the removal of suicidal behavior and ideation warnings from GLP-1 receptor agonist medications, including Saxenda (liraglutide), Wegovy (semaglutide), and Zepbound (tirzepatide). This decision followed a comprehensive review that found no increased risk of suicidal ideation or behavior associated with these medications.

These developments reflect the dynamic nature of the pharmaceutical regulatory landscape, emphasizing the importance of continuous monitoring and compliance with evolving standards.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Vildagliptin

Retail & reference prices across 9 markets vs. India FOB export price of $5.68/unit

Global Price Benchmark for Vildagliptin across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.96	USD	Pricing data sourced from PharmacyChecker.com.
United Kingdom	$0.98	GBP	Pricing data sourced from PharmacyChecker.com.
Germany	$0.93	EUR	Pricing data sourced from PharmacyChecker.com.
Australia	$0.87	AUD	Pricing data sourced from PharmacyChecker.com.

Supply Chain Risk Assessment — Vildagliptin

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

Vildagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor used in the management of type 2 diabetes, is primarily manufactured in India. However, the production of its Active Pharmaceutical Ingredient (API) is heavily reliant on Key Starting Materials (KSMs) sourced from China. This dependency is part of a broader trend where approximately 60–70% of KSMs and intermediates used in Indian pharmaceutical manufacturing are imported from China.

Recent disruptions have highlighted the vulnerabilities associated with this reliance. In September 2025, Chinese manufacturers significantly reduced the prices of 41 specific APIs and KSMs by 40% to 50%, a move perceived as an attempt to undermine India's efforts toward self-sufficiency in API production. Such pricing strategies can destabilize the Indian pharmaceutical market, making it challenging for local manufacturers to compete and sustain operations.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five Indian exporters of Vildagliptin account for 54.7% of the total export value, with AJANTA PHARMA LIMITED leading at 18.0%. This concentration suggests a moderate risk, as disruptions affecting these key suppliers could significantly impact global supply chains.

To mitigate such risks, the Indian government has implemented the Production Linked Incentive (PLI) scheme aimed at reducing import dependence on critical pharmaceutical ingredients. In November 2024, two greenfield plants were inaugurated under this scheme to manufacture essential molecules like Penicillin G and 6-Aminopenicillanic acid (6-APA), marking a significant step toward enhancing domestic production capabilities.

Access Complete Vildagliptin Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 1,149 transactions across 87 markets.

Request Demo View Pricing

Frequently Asked Questions — Vildagliptin Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top vildagliptin exporters from India?

The leading vildagliptin exporters from India are AJANTA PHARMA LIMITED, CADILA PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED, and 11 others. AJANTA PHARMA LIMITED leads with 18.0% market share ($1.8M). The top 5 suppliers together control 54.7% of total export value.

What is the total export value of vildagliptin from India?

The total export value of vildagliptin from India is $10.2M, recorded across 1,149 shipments from 178 active exporters to 87 countries. The average shipment value is $8.8K.

Which countries import vildagliptin from India?

India exports vildagliptin to 87 countries. The top importing countries are FRANCE (14.4%), PORTUGAL (10.1%), CHILE (9.1%), NETHERLANDS (8.4%), YEMEN (7.9%), which together account for 49.9% of total export value.

What is the HS code for vildagliptin exports from India?

The primary HS code for vildagliptin exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Vildagliptin

Vildagliptin

Top Vildagliptin Exporters from India

Top Countries Importing Vildagliptin from India

Who Supplies Vildagliptin to India?

Quick Facts

Related Advanced Diabetes Medications

Related Analysis

Need Details?

Regulatory Landscape — Vildagliptin

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Vildagliptin

Supply Chain Risk Assessment — Vildagliptin

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Vildagliptin Trade Intelligence

Frequently Asked Questions — Vildagliptin Exports from India

Who are the top vildagliptin exporters from India?

What is the total export value of vildagliptin from India?

Which countries import vildagliptin from India?

What is the HS code for vildagliptin exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of vildagliptin exports from India?

Which ports handle vildagliptin exports from India?

Why is India a leading exporter of vildagliptin?

What certifications do Indian vildagliptin exporters need?

How many buyers import vildagliptin from India?

What is the market share of the top vildagliptin exporter from India?

Analysis Methodology